Pharmazell Gmb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CAGR of 10.1% during the forecast period (2018-2026). Market Analysis: Rampant development of liquid ursodeoxycholic acid has offered ample growth opportunities to the companies operating in the global ursodeoxycholic acid market in the recent past. With the introduction of liquid formulations of ursodeoxycholic acid, healthcare professionals are now able to prescribe an alternate dosing method to patients who have difficulty in swallowing tablets or capsules. Extensive R&D of ursodeoxycholic acid, along with a high prevalence of diseases like gallstone and liver cirrhosis, has majorly boosted the global ursodeoxycholic acid market development. To learn more about this report, request a sample copy

United statesUnited kingdomSouth africaSouth koreaDipharma francis srlIndustria chimica emilianaAsia pacificPharmazell gmbSuzhou tianlu co ltdGlenmark pharmaceuticalIntercept pharmaceuticalsResearch objectivesDaewoong bio incAmerican gastroenterological associationRetrophin incCompany overview